Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Dusser

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Autoimmunity Reviews|July 20, 2019
Tracheobronchial involvement of relapsing polychondritisNina de Montmollin, Daniel Dusser, Christine Lorut, et al.
Investigational New Drugs|May 27, 2011
Safety of bevacizumab 7.5 mg/kg infusion over 10 minutes in NSCLC patientsOlivier Mir, Jérôme Alexandre, Romain Coriat, et al.
Medical Mycology|November 12, 2010
Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in FranceAndré Paugam, Marie-Thérèse Baixench, Nadine Demazes-Dufeu, et al.
Respiratory Research|April 4, 2013
The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationaleRobert A Wise, Antonio Anzueto, Peter Calverley, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2011
A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasmaLionel Faivre, Charline Gomo, Olivier Mir, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 5, 2015
Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycinNathalie Coolen, Philippe Morand, Clémence Martin, et al.
COPD|October 31, 2018
Postoperative outcomes of frequent exacerbator patients with Chronic Obstructive Pulmonary Disease after resection of Non-Small Cells Lung CancerSuela Demiri, Christine Lorut, Antoine Rabbat, et al.
Respiratory Medicine|September 1, 2016
Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysisRonald Dahl, Michael Engel, Daniel Dusser, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 8, 2013
Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosisDominique Hubert, Hélène Réglier-Poupet, Isabelle Sermet-Gaudelus, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 18, 2016
CFTR and/or pancreatitis susceptibility genes mutations as risk factors of pancreatitis in cystic fibrosis patients?Natacha Gaitch, Dominique Hubert, Christine Gameiro, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Autoimmunity Reviews|July 20, 2019
Tracheobronchial involvement of relapsing polychondritisNina de Montmollin, Daniel Dusser, Christine Lorut, et al.
Investigational New Drugs|May 27, 2011
Safety of bevacizumab 7.5 mg/kg infusion over 10 minutes in NSCLC patientsOlivier Mir, Jérôme Alexandre, Romain Coriat, et al.
Medical Mycology|November 12, 2010
Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in FranceAndré Paugam, Marie-Thérèse Baixench, Nadine Demazes-Dufeu, et al.
Respiratory Research|April 4, 2013
The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationaleRobert A Wise, Antonio Anzueto, Peter Calverley, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2011
A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasmaLionel Faivre, Charline Gomo, Olivier Mir, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 5, 2015
Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycinNathalie Coolen, Philippe Morand, Clémence Martin, et al.
COPD|October 31, 2018
Postoperative outcomes of frequent exacerbator patients with Chronic Obstructive Pulmonary Disease after resection of Non-Small Cells Lung CancerSuela Demiri, Christine Lorut, Antoine Rabbat, et al.
Respiratory Medicine|September 1, 2016
Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysisRonald Dahl, Michael Engel, Daniel Dusser, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 8, 2013
Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosisDominique Hubert, Hélène Réglier-Poupet, Isabelle Sermet-Gaudelus, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 18, 2016
CFTR and/or pancreatitis susceptibility genes mutations as risk factors of pancreatitis in cystic fibrosis patients?Natacha Gaitch, Dominique Hubert, Christine Gameiro, et al.
Pageof 7